230 related articles for article (PubMed ID: 21283000)
1. Soluble triggering receptor expressed on myeloid cells-1 as an infection marker for patients with neutropenic fever.
Lin CH; Yao M; Hsu SC; Ho CC; Lin MT; Lin CA; Hu FC; Yu CJ; Tien HF
Crit Care Med; 2011 May; 39(5):993-9. PubMed ID: 21283000
[TBL] [Abstract][Full Text] [Related]
2. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
von Lilienfeld-Toal M; Dietrich MP; Glasmacher A; Lehmann L; Breig P; Hahn C; Schmidt-Wolf IG; Marklein G; Schroeder S; Stuber F
Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):539-44. PubMed ID: 15221617
[TBL] [Abstract][Full Text] [Related]
3. Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia.
Koivula I; Hämäläinen S; Jantunen E; Pulkki K; Kuittinen T; Nousiainen T; Juutilainen A
Scand J Infect Dis; 2011 Jul; 43(6-7):471-8. PubMed ID: 21299364
[TBL] [Abstract][Full Text] [Related]
4. The significance of serum urokinase plasminogen activation receptor (suPAR) in the diagnosis and follow-up of febrile neutropenic patients with hematologic malignancies.
Kaya S; Köksal I; Menteşe A; Sönmez M; Sümer A; Yıldırım SS; Yılmaz G
Int J Infect Dis; 2013 Nov; 17(11):e1056-9. PubMed ID: 23742830
[TBL] [Abstract][Full Text] [Related]
5. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study.
Kofoed K; Andersen O; Kronborg G; Tvede M; Petersen J; Eugen-Olsen J; Larsen K
Crit Care; 2007; 11(2):R38. PubMed ID: 17362525
[TBL] [Abstract][Full Text] [Related]
6. Values for serum procalcitonin, C-reactive protein, and soluble triggering receptor expressed on myeloid cells-1 in predicting survival of patients with early-onset stroke-associated pneumonia.
Xie J; Zhang XH; Zhu WY
Genet Mol Res; 2015 May; 14(2):4716-23. PubMed ID: 25966246
[TBL] [Abstract][Full Text] [Related]
7. Prospective Evaluation of Procalcitonin, Soluble Triggering Receptor Expressed on Myeloid Cells-1 and C-Reactive Protein in Febrile Patients with Autoimmune Diseases.
Lin CH; Hsieh SC; Keng LT; Lee HS; Chang HT; Liao WY; Ho CC; Yu CJ
PLoS One; 2016; 11(4):e0153938. PubMed ID: 27096761
[TBL] [Abstract][Full Text] [Related]
8. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia.
Secmeer G; Devrim I; Kara A; Ceyhan M; Cengiz B; Kutluk T; Buyukpamukcu M; Yetgin S; Tuncer M; Uludag AK; Tezer H; Yildirim I
J Pediatr Hematol Oncol; 2007 Feb; 29(2):107-11. PubMed ID: 17279007
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
10. [Expression of soluble triggering receptor expressed on myeloid cells-1 in septic patients and its relation with prognosis].
Sun J; Song SD; Zhao HJ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 May; 23(5):305-8. PubMed ID: 21549071
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia.
Miedema KG; de Bont ES; Elferink RF; van Vliet MJ; Nijhuis CS; Kamps WA; Tissing WJ
Support Care Cancer; 2011 Oct; 19(10):1593-600. PubMed ID: 20803037
[TBL] [Abstract][Full Text] [Related]
12. Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia.
Persson L; Engervall P; Magnuson A; Vikerfors T; Söderquist B; Hansson LO; Tidefelt U
Scand J Infect Dis; 2004; 36(5):365-71. PubMed ID: 15287382
[TBL] [Abstract][Full Text] [Related]
13. The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*.
Debiane L; Hachem RY; Al Wohoush I; Shomali W; Bahu RR; Jiang Y; Chaftari AM; Jabbour J; Al Shuaibi M; Hanania A; Pravinkumar SE; Schuetz P; Raad I
Crit Care Med; 2014 Dec; 42(12):2500-7. PubMed ID: 25083975
[TBL] [Abstract][Full Text] [Related]
14. Use of soluble triggering receptor expressed on myeloid cells-1 in non-tuberculous mycobacterial lung disease.
Shu CC; Lee LN; Wu MF; Lee CH; Wang JT; Wang JY; Yu CJ;
Int J Tuberc Lung Dis; 2011 Oct; 15(10):1415-20. PubMed ID: 22283904
[TBL] [Abstract][Full Text] [Related]
15. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
Chayakulkeeree M; Thamlikitkul V
J Med Assoc Thai; 2003 Mar; 86(3):212-23. PubMed ID: 12757060
[TBL] [Abstract][Full Text] [Related]
16. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis.
Gibot S; Cravoisy A; Kolopp-Sarda MN; Béné MC; Faure G; Bollaert PE; Levy B
Crit Care Med; 2005 Apr; 33(4):792-6. PubMed ID: 15818107
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II.
Fleischhack G; Kambeck I; Cipic D; Hasan C; Bode U
Br J Haematol; 2000 Dec; 111(4):1093-102. PubMed ID: 11167745
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer.
Fleischhack G; Cipic D; Juettner J; Hasan C; Bode U
Intensive Care Med; 2000 Mar; 26 Suppl 2():S202-11. PubMed ID: 18470721
[TBL] [Abstract][Full Text] [Related]
19. High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis.
Huang CT; Lee LN; Ho CC; Shu CC; Ruan SY; Tsai YJ; Wang JY; Yu CJ
J Infect; 2014 May; 68(5):440-7. PubMed ID: 24393650
[TBL] [Abstract][Full Text] [Related]
20. Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C-reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy.
Xiao Y; Luo H; Zhou B; Dai X; Huang J; Duan L; You Y; Zhang W; Zhao H; Xie Y; Zhou Y; Ning W; Li T; Liu S; Zhu H; Xie X; Jiang Y; Wu S; He W; Li Y
Rheumatol Int; 2017 Apr; 37(4):585-592. PubMed ID: 27878344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
